This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Has Select Medical Holdings (SEM) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
Select Medical (SEM) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Select Medical (SEM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Select Medical (SEM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Select Medical (SEM) closed the most recent trading day at $39.94, moving +0.99% from the previous trading session.
Here's What Could Help Select Medical (SEM) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Select Medical (SEM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Humana (HUM) Arm to Offer Original Medicare Members Holistic Care
by Zacks Equity Research
Humana's (HUM) CenterWell to provide value-based health care to Original Medicare beneficiaries.
Encompass Health (EHC) Buys Frontier, Boosts Home Health Services
by Zacks Equity Research
Encompass Health (EHC) completes the purchase of Frontier, which reflects its efforts to offer enhanced care across several states.
Can Select Medical (SEM) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Select Medical (SEM).
Here's How Much You'd Have If You Invested $1000 in Select Medical a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on its inorganic growth story and an improving membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
HCA Healthcare (HCA) Ties Up for Accelerating Digital Processes
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with Google Cloud with an aim to speed up digital transformation of the former, resulting in enhanced clinical and operational processes.
5 Solid Reasons Why The Joint (JYNT) Looks Attractive Now
by Zacks Equity Research
The Joint Corp. 's (JYNT) resilient business model along with its long-term expansion plans makes it a perfect fit for your investment portfolio.
HCA Healthcare (HCA) to Rebrand Certain Units in Florida
by Zacks Equity Research
HCA Healthcare (HCA) to adopt the HCA Florida Healthcare brand to enhance its appeal and solidify its presence.
Select Medical (SEM) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Select Medical (SEM) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
6 Top Ranked Stocks With Impressive Net Profit Margins
by Anirudha Bhagat
Let's take a look at the six top ranked stocks with impressive net profit margins for an enriching portfolio.
Anthem (ANTM), Epic Collaborate for Better Consumer Experience
by Zacks Equity Research
Anthem (ANTM) teams up with health information company Epic for bridging the gaps in medical care with near real-time data.
Is Select Medical Holdings (SEM) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
Tenet Healthcare (THC) Offers Senior Notes Worth $1.4 B
by Zacks Equity Research
Tenet Healthcare (THC) exhibits prudence by issuing notes to procure funds and pay down its existing debt.
HCA Healthcare (HCA) to Divest Hospital for Better Liquidity
by Zacks Equity Research
HCA Healthcare (HCA) to sell Redmond Regional Medical Center, GA to AdventHealth for boosting financial solvency.
Select Medical (SEM) Banks on Top-Line Growth, Solid Cash Flows
by Zacks Equity Research
Select Medical (SEM) gains from constant top-line growth, strong 2021 business outlook and solid cash balance.
Here's How Much You'd Have If You Invested $1000 in Select Medical a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Why Fast-paced Mover Select Medical (SEM) Is a Great Choice for Value Investors
by Zacks Equity Research
Select Medical (SEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Select Medical (SEM) Beats on Q1 Earnings, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) first-quarter results indicate uptick in revenues stemming from solid segmental performances except Outpatient Rehabilitation, partly offset by higher costs.
Select Medical (SEM) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 26.15% and 4.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?